“Evaluation of Paclitaxel As a Non-Cross-Resistant Agent in Cisplatin-Resistant Small Cell Lung Cancer (SCLC)”. International Cancer Research Journal 1, no. 1 (September 25, 2025): 2. Accessed February 6, 2026. https://icrj.meteorpub.com/1/article/view/7.